Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX)
(Delayed Data from NSDQ)
$6.15 USD
-0.05 (-0.81%)
Updated Oct 31, 2024 03:59 PM ET
After-Market: $6.24 +0.09 (1.46%) 7:22 PM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | NA |
---|---|
Current Quarter | NA |
EPS Last Quarter | NA |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
NA |
---|---|
Current Year | -3.00 |
Next Year | -2.00 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | NA | NA | 0.47M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | -3.00 | -2.00 |
# of Estimates | NA | NA | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | NA | NA | -3.00 | -2.00 |
Low Estimate | NA | NA | -3.00 | -2.00 |
Year ago EPS | NA | NA | -248.75 | -3.00 |
Year over Year Growth Est. | NA | NA | 98.79% | 33.33% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | NA | NA | 0 | 0 |
Up Last 30 Days | NA | NA | 0 | 0 |
Up Last 60 Days | NA | NA | 0 | 0 |
Down Last 7 Days | NA | NA | 0 | 0 |
Down Last 30 Days | NA | NA | 0 | 0 |
Down Last 60 Days | NA | NA | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | NA | NA | -3.00 | -2.00 |
7 Days Ago | NA | NA | -3.00 | -2.00 |
30 Days Ago | NA | NA | -3.00 | -2.00 |
60 Days Ago | NA | NA | -3.00 | -2.00 |
90 Days Ago | NA | NA | -3.00 | -2.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | NA | NA | -3.00 | -2.00 |
Zacks Consensus Estimate | NA | NA | -3.00 | -2.00 |
Earnings ESP | NA | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | NA | NA | NA | NA | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more